Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/206797
Kind Code:
A1
Abstract:
Compounds of formula A, a method for using said compounds as an EGFR inhibitor, and a pharmaceutical composition comprising said compounds. The compounds can be used to treat, prevent or ameliorate diseases or conditions such as cancers or infections.

Inventors:
QIU CHANGYONG (CN)
SONG XIAODONG (CN)
SHEN QICHAO (CN)
LIU XIANGYONG (CN)
DING LIEMING (CN)
WANG JIABING (CN)
Application Number:
PCT/CN2022/083919
Publication Date:
October 06, 2022
Filing Date:
March 30, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BETTA PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D239/48; A61K31/506; A61P35/00; C07D401/14; C07D409/14; C07D417/14; C07D471/10; C07D487/04; C07D487/10
Domestic Patent References:
WO2021203131A12021-10-07
WO2011130390A12011-10-20
WO2010129053A22010-11-11
Foreign References:
CN110467638A2019-11-19
CN106083828A2016-11-09
CN105017160A2015-11-04
CN111587244A2020-08-25
KR20200016567A2020-02-17
CN110835320A2020-02-25
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: PEGYLATED RAPAMYCIN COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Next Patent: TECHNIQUES FOR PARTIAL FREQUENCY SOUNDING WITH FREQUENCY HOPPING